March 20, 2019
Genetech Failure

The Danger of Using Donor-derived Materials Without Good Quality Control: the Liveyon Debacle – Part Two

In the previous post, I had begun to review the Warning Letter the FDA issued to Genetech, who was the supplier of cord blood-derived products to Liveyon, who in turn sold the contaminated vials of their product to physicians across the USA. While the most shocking observation the FDA made in the Warning Letter was...
Read More